BCLSI
Bain Capital Life Sciences Investors’s Annexon ANNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Hold |
5,249,069
| – | – | 1.58% | 14 |
|
|
2025
Q1 | $10.1M | Hold |
5,249,069
| – | – | 1.5% | 12 |
|
|
2024
Q4 | $26.9M | Sell |
5,249,069
-3,200,679
| -38% | -$16.4M | 3.17% | 9 |
|
|
2024
Q3 | $50M | Buy |
8,449,748
+540
| +0% | +$3.2K | 5.2% | 7 |
|
|
2024
Q2 | $41.4M | Sell |
8,449,208
-254,060
| -3% | -$1.24M | 4.55% | 7 |
|
|
2024
Q1 | $62.4M | Buy |
8,703,268
+641,549
| +8% | +$4.6M | 5.02% | 8 |
|
|
2023
Q4 | $36.6M | Buy |
8,061,719
+2,359,793
| +41% | +$10.7M | 3.51% | 8 |
|
|
2023
Q3 | $13.5M | Hold |
5,701,926
| – | – | 1.5% | 18 |
|
|
2023
Q2 | $20.1M | Buy |
5,701,926
+815,310
| +17% | +$2.87M | 2.07% | 16 |
|
|
2023
Q1 | $18.8M | Hold |
4,886,616
| – | – | 2.35% | 16 |
|
|
2022
Q4 | $25.3M | Buy |
4,886,616
+1,284,690
| +36% | +$6.64M | 2.82% | 12 |
|
|
2022
Q3 | $22.3M | Buy |
3,601,926
+360,298
| +11% | +$2.23M | 2.66% | 14 |
|
|
2022
Q2 | $12.2M | Hold |
3,241,628
| – | – | 1.43% | 18 |
|
|
2022
Q1 | $8.85M | Hold |
3,241,628
| – | – | 0.86% | 22 |
|
|
2021
Q4 | $37.2M | Hold |
3,241,628
| – | – | 2.95% | 11 |
|
|
2021
Q3 | $60.3M | Hold |
3,241,628
| – | – | 3.74% | 10 |
|
|
2021
Q2 | $73M | Hold |
3,241,628
| – | – | 4.78% | 6 |
|
|
2021
Q1 | $90.2M | Hold |
3,241,628
| – | – | 5.11% | 5 |
|
|
2020
Q4 | $81.1M | Hold |
3,241,628
| – | – | 5.09% | 5 |
|
|
2020
Q3 | $98M | Buy |
+3,241,628
| New | +$98M | 9.13% | 3 |
|